Association of plasma xanthine oxidoreductase activity with vascular endothelial function independent of serum uric acid level: MedCity21 health examination registry

BACKGROUND: Xanthine oxidoreductase (XOR) inhibitor administration, known to reduce uric acid and reactive oxygen species (ROS) production, also improves vascular endothelial function (VEF). This cross-sectional study examined our hypothesis that XOR contributes to impaired VEF through ROS but not u...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurajoh, Masafumi, Fukumoto, Shinya, Akari, Seigo, Murase, Takayo, Nakamura, Takashi, Ihara, Yasutaka, Imai, Takumi, Nagata, Yuki, Morioka, Tomoaki, Mori, Katsuhito, Imanishi, Yasuo, Watanabe, Toshio, Emoto, Masanori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10480664/
https://www.ncbi.nlm.nih.gov/pubmed/37680549
http://dx.doi.org/10.1016/j.ijcha.2023.101264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10480664/
https://www.ncbi.nlm.nih.gov/pubmed/37680549
http://dx.doi.org/10.1016/j.ijcha.2023.101264

Ejemplares similares